MCRI presents a positive liquidation recovery posture relative to most operating companies, driven by a largely tangible, owned asset base and zero funded debt. At March 31, 2026, total assets are $725.2M against total liabilities of $175.3M, leaving book equity of $549.8M. Under liquidation haircuts, the dominant asset is PP&E net of $551.5M (gross $963.5M, accumulated depreciation $411.9M). Applying a 50-70% recovery to net PP&E yields approximately $276M-$386M. Cash recovers at 100% ($120.1M). AR net ($9.7M) recovers at ~90-95% (~$9.2M). Inventory ($8.3M) recovers at ~60% (~$5.0M). Goodwill ($25.1M) receives zero recovery. Prepaid and other current assets ($8.7M) receive modest recovery. Total adjusted asset recovery estimate: roughly $425M-$535M. Against this, liabilities must be settled at face value: total liabilities $175.3M, of which current liabilities are $150.6M. The current liability stack is heavily distorted by the PCL litigation reserve: $48.2M in ConstructionPayableCurrent and $31.5M of the $45.4M AccountsPayableCurrent are attributed to the PCL judgment, totaling $78.5M accrued for that contingency as of the filing date. The February 14, 2025 court judgment awarded PCL a net principal of $74.6M; Monarch has posted a bond and appealed, with briefing ongoing. The accrual also includes post-judgment interest ($1.1M accrued in Q1 2026). This litigation liability is carried at face value under the liquidation lens regardless of appeal outcome uncertainty. Operating lease liabilities of $13.0M (current $1.0M, noncurrent $12.1M) also survive windup. Deferred tax liabilities of $11.6M are included in non-current liabilities. Net recovery to equity under this framework is positive but sensitive to PP&E realization rate and PCL outcome. Compared to the prior filing (FY2025 10-K, December 31, 2025), the key changes are: (1) cash grew materially from operating cash generation ($48.5M from operations in Q1 2026); (2) PP&E net declined modestly from $556.7M to $551.5M as D&A ($10.5M) exceeded capex additions; (3) stock repurchases of $17.7M and dividends of $5.4M reduced equity; (4) $1.1M of PCL interest accrued in Q1 2026 was added to the litigation reserve, bringing total PCL accrual to $78.5M. No new debt drawn; revolver remains undrawn with $99.4M available. Filing discloses goodwill impairment testing as passing qualitative assessment for Q1 2026; no interim impairment charge recorded. The 'One Big Beautiful Bill Act' enacted July 4, 2025 making 100% bonus depreciation permanent is noted but impact evaluation is ongoing—not yet reflected in deferred tax balances as of this filing.
▼ Community Notes